NCT03195868View on ClinicalTrials.gov

Photobiomodulation Therapy and Nerve Density for Patients With Diabetic or Chemotherapy-associated Neuropathy

NACompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

September 30, 2019

Primary Completion Date

January 21, 2021

Study Completion Date

January 21, 2021

Conditions
NeuropathyNeuropathy, DiabeticNeuropathy Toxic
Interventions
DEVICE

Realief Therapy

Patients will be treated using class IV laser using a proprietary algorithm developed by REALief neuropathy centers

Trial Locations (1)

55455

University of Minnesota, Minneapolis

All Listed Sponsors
lead

University of Minnesota

OTHER

NCT03195868 - Photobiomodulation Therapy and Nerve Density for Patients With Diabetic or Chemotherapy-associated Neuropathy | Biotech Hunter | Biotech Hunter